Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer Global Research and Development
Woman and Man Max 99 years
Pfizer Global Research and Development
Update Il y a 4 ans
Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections
The primary objective of this study is to compare the microbiological efficacy of linezolid to vancomycin/oxacillin/dicloxacillin in the empiric treatment of patients with gram-positive catheter-relat...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Limited. Pfizer Global Research and Development
Update Il y a 4 ans
Full title of the trial: A 9 Week, Randomized, Double-Blind, placebo-controlled, Multicenter, Study of Pregabalin (BID) in subjects with posttraumatic peripheral neuropathic pain
To evaluate the efficacy of pregabalin compared to placebo in the treatment of post traumatic peripheral neuropathic pain.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Global Research and Development (USA)
Update Il y a 4 ans
An Evaluation of the Effects of Roflumilast on Cardiac Repolarization, Pharmacokinetics, Safety, and Tolerability in Healthy Volunteers
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Global Research and Development
Update Il y a 4 ans
A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety and Efficacy of AG-013958 in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration
To determine the ocular and systemic safety of AG-013958 Suspension for Injection for 13 weeks following administration of a single ST injection and for 104 weeks following multiple administrations by...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Pfizer Global Research and Development
Update Il y a 4 ans
An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone deficiency
To explore the pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in AGHD patients in order to support the development of a PK/PD model in this patient population...
Country
None
organs
None
Specialty
None
Closed trial
More information